Guardant Health Stock Analysis

Guardant Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.32. Guardant Health had not issued any dividends in recent years. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company was incorporated in 2011 and is headquartered in Redwood City, California. Guardant Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1373 people. To learn more about Guardant Health call Helmy Eltoukhy at 855 698 8887 or check out https://guardanthealth.com.

Guardant Health Investment Alerts

Guardant Largest EPS Surprises

View All Earnings Estimates

Guardant Health Environmental, Social, and Governance (ESG) Scores

Guardant Stock Institutional Investors

Note, although Guardant Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Guardant Market Capitalization

The company currently falls under 'Large-Cap' category with a market capitalization of 14.81 B.

Guardant Profitablity

The company has Net Profit Margin (PM) of (0.44) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.37) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.37.

Management Efficiency

Guardant Health has Return on Asset (ROA) of (0.1964) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1964. This is way below average. Likewise, it shows a return on total equity (ROE) of (45.8447) %, which implies that it produced no returns to current stockholders. Guardant Health's management efficiency ratios could be used to measure how well Guardant Health manages its routine affairs as well as how well it operates its assets and liabilities. The Guardant Health's current Return On Equity is estimated to increase to 3.77, while Return On Tangible Assets are projected to decrease to (0.36). As of now, Guardant Health's Intangibles To Total Assets are decreasing as compared to previous years. The Guardant Health's current Debt To Assets is estimated to increase to 0.85, while Total Assets are projected to decrease to under 1.4 B.

Technical Drivers

As of the 1st of February, Guardant Health retains the risk adjusted performance of 0.145, and Market Risk Adjusted Performance of 2.73. Guardant Health technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Guardant Health Price Movement Analysis

Guardant Health Insider Trading Activities

Guardant Health Outstanding Bonds

Guardant Health Predictive Daily Indicators

Guardant Health Corporate Filings

Guardant Health Forecast Models

Guardant Health's time-series forecasting models are one of many Guardant Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Guardant Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Guardant Health Bond Ratings

Guardant Health financial ratings play a critical role in determining how much Guardant Health have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Guardant Health's borrowing costs.

Guardant Health Debt to Cash Allocation

Guardant Health reports 1.34 B of total liabilities with total debt to equity ratio (D/E) of 4.32, which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Guardant Health has a current ratio of 6.06, indicating that it is in good position to pay out its debt commitments in time. Note however, debt could still be an excellent tool for Guardant to invest in growth at high rates of return.

Guardant Health Total Assets Over Time

Guardant Health Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Guardant Health uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Guardant Health Debt Ratio

85.0

It feels like most of the Guardant Health's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Guardant Health's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Guardant Health, which in turn will lower the firm's financial flexibility.

Guardant Health Corporate Bonds Issued

Guardant Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Guardant Health. By using and applying Guardant Stock analysis, traders can create a robust methodology for identifying Guardant entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Guardant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Guardant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Guardant Health stock analysis indicators help investors evaluate how Guardant Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Guardant Health shares will generate the highest return on investment. By understating and applying Guardant Health stock analysis, traders can identify Guardant Health position entry and exit signals to maximize returns.

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.